₩15200.00
₩0.00 (0.00%)
End-of-day quote: 05/17/2024
KOSE:A249420
Ildong Pharmaceutical Annual Report
| Year | Year | 2023 | 2022 | 2019 | 2018 | 2017 | ||
|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩600.76B | ₩637.71B | ₩517.47B | ₩503.91B | ₩460.65B | |
| GM % | Gross Margin % |
|
35.56% | 37.03% | 44.85% | 50.59% | 49.07% | |
| OM | Operating Margin |
|
-8.89% | -11.55% | -0.30% | 5.39% | 5.51% | |
| EPS | Earnings Per Share |
|
₩0.00 | ₩-3338.00 | ₩-5363.00 | ₩-598.00 | ₩534.29 | ₩896.15 |
| Div. | Dividends |
|
₩0.00 | ₩0.00 | ₩380.95 | ₩380.95 | ₩362.81 | |
| PR % | Payout Ratio % |
|
0 | 0 | -63.70% | 71.30% | 40.49% | |
| Sha. | Shares |
|
27.93m | 26.79m | 23.79m | 22.66m | 21.63m | |
| OCF | Operating Cash Flow |
|
₩-36615.40M | ₩-53540.65M | ₩41.37B | ₩66.65B | ₩73.72B | |
| FCF | Free Cash Flow |
|
₩-101000.00M | ₩-54000.00M | ₩28.37B | ₩50.67B | ₩55.93B | |
| FCFS | Free Cash Flow Per Share |
|
₩-1915.83 | ₩-2726.05 | ₩1.01k | ₩1.94k | ₩1.31k |
